Medidata Solutions President Glen de Vries Named to Crain’s 40 Under 40

FOR IMMEDIATE RELEASE
 

Clinical Trial Technology Innovator Recognized for
Industry Leadership and Business Success

NEW YORK, N.Y. – March 30, 2010 – Medidata Solutions (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, today announced that President and Co-founder Glen de Vries has been named one of Crain’s 40 Under 40, an annual list of rising business stars who have excelled in their respective fields.

Each year, a panel of Crain's editors and reporters spotlights a diverse group of young entrepreneurs based on their individual perseverance, professional success and community leadership. De Vries is being honored for his efforts in helping drive Medidata to a position of industry leadership in bringing advanced technologies to the development of drugs and other medical treatments and creating a thriving, profitable enterprise that employs hundreds worldwide. Medidata’s growth culminated in a successful IPO in June 2009—one of only eight tech-related IPOs that year.

“Glen’s business and technology vision, combined with his relentless drive to deliver on his personal and professional goals, have been essential to our company’s success,” said Tarek Sherif, CEO of Medidata Solutions. “Glen shapes our vision and product strategy, inspires and mentors our worldwide team and embodies our corporate culture of collaboration with our customers, which is the basis of our business and industry success.”

Combining a scientist’s background with computer talents and people skills, de Vries laid the foundation and subsequent development path for Medidata Rave®, an easy-to-use, Internet-based solution for electronic collection, management and reporting of clinical data that brings multiple efficiencies and enhancements to drug development teams at research companies and clinical sites including hospitals and doctors’ offices. As the chief architect of Rave, de Vries worked closely over the past 10 years with clinical research departments at some of the world’s largest pharmaceutical companies, academic institutions and research organization, including AstraZeneca, Bayer, and Pfizer, to bring advanced software infrastructure to the critical and costly stage of clinical drug development.

"Glen de Vries made his mark with Medidata by launching one of the few successful technology-related IPOs of the past 10 months. This made him an obvious candidate for Crain's 40 Under 40 list. We are happy to honor his accomplishments as well as those of all the rising stars in the 2010 class of 40 Under 40," said Valerie Block, Deputy Managing Editor of Crain's New York Business.

De Vries continues to contribute regularly to organizations supporting basic scientific research, including amFAR, the Pittsburgh Tissue Engineering Institute and local New York universities. He frequently presents at health technology conferences worldwide, including Drug Information Association meetings and the National Medical Association Annual Meeting.

About Medidata Solutions Worldwide
Medidata Solutions (www.mdsol.com) is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers’ clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer®), investigator benchmarking and budgeting (Medidata Grants Manager™), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor™), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave®). Medidata’s diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies.

About Crain’s 40 Under 40
For more than 20 years, Crain's New York Business has been honoring talented businesspeople under 40 who work in a wide variety of industries in the most dynamic city in the world. In our annual "40 Under 40" issue, we highlight each honoree's successes and provide a look at the winners' backgrounds, their work ethic and the myriad forces that shaped them into the leaders they are today. Their stories are told in lively print profiles in Crain's New York Business, as well as in video interviews accessible at www.crainsnewyork.com.

Contact:
Susan McCarron
Lois Paul & Partners
781.782.5767
Susan_McCarron@lpp.com